Johns Hopkins Bloomberg School of Public Health

NCT07077486

Collaborator, Phase 4, Recruiting, 2025, 100 people, 22 Jul 2025, clinicaltrials.gov

The Sedentary to Active Rising to Thrive (START) Trial

No phase, Active, not recruiting, 2023, 61 people, 5 Sept 2023, clinicaltrials.gov

NCT02995005

Phase 1/2, Completed, 2018, 98 people, 16 Dec 2016, clinicaltrials.gov

NCT01126528

Phase 2, Completed, 2010, 160 people, 19 May 2010, clinicaltrials.gov

NCT01034254

Collaborator, Phase 3, Completed, 2010, 3,693 people, 17 Dec 2009, clinicaltrials.gov

NCT00938600

Phase 1, Completed, 2009, 75 people, 14 Jul 2009, clinicaltrials.gov

NCT00470158

Phase 4, Completed, 2007, 1,000 people, 7 May 2007, clinicaltrials.gov

NCT00255385

Phase 3, Completed, 2002, 1,200 people, 18 Nov 2005, clinicaltrials.gov

NCT00198718

Phase 2, Completed, 1997, 28,220 people, 20 Sept 2005, clinicaltrials.gov

NCT00138047

Phase 2, Completed, 2003, 100 people, 30 Aug 2005, clinicaltrials.gov

NCT00128557

Phase 3, Completed, 2004, 15,937 people, 10 Aug 2005, clinicaltrials.gov

NCT00114868

Phase 3, Completed, 1998, 14,035 people, 20 Jun 2005, clinicaltrials.gov

Association between midlife macronutrient intake and late-life hearing loss: the Atherosclerosis Risk in Communities Study

Consulting or advice, Board or leadership role, 5 Sept 2026, pubmed.ncbi.nlm.nih.gov

Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

Board or leadership role, 3 Sept 2026, pubmed.ncbi.nlm.nih.gov